Lanreotide D8

Product Name Lanreotide D8
Alternate Names Lanreotide Stable Isotopes, Stable Isotopes of Lanreotide
CAT No. CS-O-15453
CAS No. 108736-35-2(Unlabeled)
Category Stable Isotopes
Stock IN-Stock
Mol. Wt. 1104.37 g/mol
Mol. For. C₅₄H₆₁D₈N₁₁O₁₀S₂
Hazardous This is a Hazardous Compound
COA View Sample COA
MSDS View Sample MSDS
Parent API Lanreotide
Purity >98%
Therapeutic Anti-Cancer / Oncology
Smileys O=C(N[C@@](C(N[C@@]1([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)([H])CCCCN)[C@H](NC([C@@H](NC([C@@](CSSC[C@@H](C(N[C@H](C(N)=O)[C@H](O)C)=O)NC1=O)([H])NC([C@H](N)CC2=CC3=CC=CC=C3C=C2)=O)=O)CC4=CC=C(O)C=C4)=O)CC5=CNC6=C5C=CC=C6
Canonical Smiles CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N
InchIKey PUDHBTGHUJUUFI-UHFFFAOYSA-N
Inchl InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)
IUPAC 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
Controlled No
Shipping Free for purchase above 1000$
Delivery In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries.
Return Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product).
Ordering Place your order online or by email sales@clearsynth.com
Lanreotide D8 is a synthetic octapeptide that has been designed to mimic the natural hormone somatostatin. It is a modified version of the original lanreotide molecule, which has been labeled with eight deuterium atoms (D8) in order to improve its stability and pharmacological properties. Lanreotide D8 is primarily used in the treatment of acromegaly, a hormonal disorder caused by the excessive production of growth hormone (GH) by the pituitary gland. It works by binding to the somatostatin receptors on the pituitary gland, which reduces the secretion of GH, thereby alleviating the symptoms of acromegaly. In addition to acromegaly, lanreotide D8 has also been used in the treatment of other hormone-related disorders such as neuroendocrine tumors, carcinoid syndrome, and polycystic ovary syndrome. From a chemical standpoint, lanreotide D8 has a molecular weight of 1182.5 g/mol and a chemical formula of C54H69N11O10S2. It is a peptide molecule consisting of eight amino acids, with a disulfide bond between two of the amino acids. Overall, lanreotide D8 is a valuable therapeutic agent for the treatment of hormone-related disorders, and its unique chemical properties make it a promising candidate for further development and research.

This page contains information about Lanreotide D8. You can buy Lanreotide D8 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Lanreotide D8